What is the focus of
our research?

Using GPS D2, PharmaBUG and other proprietary know-how BIOALVO develops new compounds that will be the future therapeutics in CNS.

The recognition of technology competitiveness and BIOALVO’s core competences created the opportunity to establish partnerships all over the world and to participate in leading R&D consortia.

The involvement in these R&D partnerships will contribute significantly to the cutting edge development of research in CNS diseases while extending BIOALVO’s collaborations network in Portugal and abroad .